266
Views
12
CrossRef citations to date
0
Altmetric
Original Investigations

Repeated cocaine exposure dysregulates BDNF expression and signaling in the mesocorticolimbic pathway of the adolescent rat

, , , &
Pages 531-544 | Received 07 Dec 2017, Accepted 17 Jan 2018, Published online: 21 Feb 2018

References

  • Altar CA, Cai N, Bliven T, Juhasz M, Conner JM, Acheson AL, Lindsay RM, Wiegand SJ. 1997. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature. 389(6653):856–860.
  • Augur IF, Wyckoff AR, Aston-Jones G, Kalivas PW, Peters J. 2016. Chemogenetic activation of an extinction neural circuit reduces cue-induced reinstatement of cocaine seeking. J Neurosci. 36:10174–10180.
  • Autry AE, Monteggia LM. 2012. Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev. 64:238–258.
  • Baker DA, Xi ZX, Shen H, Swanson CJ, Kalivas PW. 2002. The origin and neuronal function of in vivo nonsynaptic glutamate. J Neurosci. 22:9134–9141.
  • Berglind WJ, See RE, Fuchs RA, Ghee SM, Whitfield TW Jr., Miller SW, McGinty JF. 2007. A BDNF infusion into the medial prefrontal cortex suppresses cocaine seeking in rats. Eur J Neurosci. 26:757–766.
  • Berglind WJ, Whitfield TW, Jr., LaLumiere RT, Kalivas PW, McGinty JF. 2009. A single intra-PFC infusion of BDNF prevents cocaine-induced alterations in extracellular glutamate within the nucleus accumbens. Neurosci. 29:3715–3719.
  • Caballero A, Granberg R, Tseng KY. 2016. Mechanisms contributing to prefrontal cortex maturation during adolescence. Neurosci Biobehav Rev. 70:4–12.
  • Caffino L, Giannotti G, Mottarlini F, Racagni G, Fumagalli F. 2017. Developmental exposure to cocaine dynamically dysregulates cortical Arc/Arg3.1 modulation in response to a challenge. Neurotox Res. 31:289–297.
  • Chapman RH, Stern JM. 1978. Maternal stress and pituitary-adrenal manipulations during pregnancy in rats: effects on morphology and sexual behavior of male offspring. J Comp Physiol Psychol. 92:1074–1083.
  • Chiaruttini C, Sonego M, Baj G, Simonato M, Tongiorgi E. 2008. BDNF mRNA splice variants display activity-dependent targeting to distinct hippocampal laminae. Mol Cell Neurosci. 37:11–19.
  • Collins SL, Izenwasser S. 2004. Chronic nicotine differentially alters cocaine-induced locomotor activity in adolescent vs. adult male and female rats. Neuropharmacology. 46:349–362.
  • Conner JM, Lauterborn JC, Yan Q, Gall CM, Varon S. 1997. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci. 17:2295–2313.
  • Filip M, Faron-Gorecka A, Kusmider M, Golda A, Frankowska M, Dziedzicka-Wasylewska M. 2006. Alterations in BDNF and trkB mRNAs following acute or sensitizing cocaine treatments and withdrawal. Brain Res. 1071:218–225.
  • Fumagalli F, Caffino L, Racagni G, Riva MA. 2009. Repeated stress prevents cocaine-induced activation of BDNF signaling in rat prefrontal cortex. Eur Neuropsychopharmacol. 19:402–408.
  • Fumagalli F, Di Pasquale L, Caffino L, Racagni G, Riva MA. 2007. Repeated exposure to cocaine differently modulates BDNF mRNA and protein levels in rat striatum and prefrontal cortex. Eur J Neurosci. 26:2756–2763.
  • Fumagalli F, Moro F, Caffino L, Orru A, Cassina C, Giannotti G, Di Clemente A, Racagni G, Riva MA, Cervo L. 2013. Region-specific effects on BDNF expression after contingent or non-contingent cocaine i.v. self-administration in rats. Int J Neuropsychopharmacol. 16:913–918.
  • Fumagalli F, Racagni G, Riva MA. 2006a. The expanding role of BDNF: a therapeutic target for Alzheimer's disease?. Pharmacogenomics J. 6:8–15.
  • Fumagalli F, Racagni G, Riva MA. 2006b. Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease. Pharmacogenomics J. 6:95–104.
  • Georges F, Aston-Jones G. 2002. Activation of ventral tegmental area cells by the bed nucleus of the stria terminalis: a novel excitatory amino acid input to midbrain dopamine neurons. J Neurosci. 22:5173–5187.
  • Giannotti G, Caffino L, Calabrese F, Racagni G, Riva MA, Fumagalli F. 2014. Prolonged abstinence from developmental cocaine exposure dysregulates BDNF and its signaling network in the medial prefrontal cortex of adult rats. Int J Neuropsychopharmacol. 17:625–634.
  • Giannotti G, Caffino L, Mottarlini F, Racagni G, Fumagalli F. 2016. Region-specific effects of developmental exposure to cocaine on fibroblast growth factor-2 expression in the rat brain. Psychopharmacology (Berl). 233:2699–2704.
  • Go BS, Barry SM, McGinty JF. 2016. Glutamatergic neurotransmission in the prefrontal cortex mediates the suppressive effect of intra-prelimbic cortical infusion of BDNF on cocaine-seeking. Eur Neuropsychopharmacol. 26:1989–1999.
  • Graham DL, Edwards S, Bachtell RK, DiLeone RJ, Rios M, Self DW. 2007. Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nat Neurosci. 10:1029–1037.
  • Grimm JW, Lu L, Hayashi T, Hope BT, Su TP, Shaham Y. 2003. Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J Neurosci. 23:742–747.
  • Gulyaeva NV. 2017. Interplay between brain BDNF and glutamatergic systems: a brief state of the evidence and association with the pathogenesis of depression. Biochemistry (Mosc). 82:301–307.
  • Hall RA, Soderling TR. 1997. Differential surface expression and phosphorylation of the N-methyl-D-aspartate receptor subunits NR1 and NR2 in cultured hippocampal neurons. J Biol Chem. 272:4135–4140.
  • Hinton EA, Wheeler MG, Gourley SL. 2014. Early-life cocaine interferes with BDNF-mediated behavioral plasticity. Learn Mem. 21:253–257.
  • Ivanov A, Pellegrino C, Rama S, Dumalska I, Salyha Y, Ben-Ari Y, Medina I. 2006. Opposing role of synaptic and extrasynaptic NMDA receptors in regulation of the extracellular signal-regulated kinases (ERK) activity in cultured rat hippocampal neurons. J Physiol. 572:789–798.
  • Kalivas PW. 2009. The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci. 10:561–572.
  • Kelley AE, Schochet T, Landry CF. 2004. Risk taking and novelty seeking in adolescence: introduction to part I. Ann NY Acad Sci. 1021:27–32.
  • KhorshidAhmad T, Acosta C, Cortes C, Lakowski TM, Gangadaran S, Namaka M. 2016. Transcriptional regulation of brain-derived neurotrophic factor (BDNF) by Methyl CpG binding protein 2 (MeCP2): a novel mechanism for re-myelination and/or myelin repair involved in the treatment of multiple sclerosis (MS). Mol Neurobiol. 53:1092–1107.
  • Li X, DeJoseph MR, Urban JH, Bahi A, Dreyer JL, Meredith GE, Ford KA, Ferrario CR, Loweth JA, Wolf ME. 2013. Different roles of BDNF in nucleus accumbens core versus shell during the incubation of cue-induced cocaine craving and its long-term maintenance. J Neurosci. 33:1130–1142.
  • Lu L, Dempsey J, Liu SY, Bossert JM, Shaham Y. 2004. A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal. J Neurosci. 24:1604–1611.
  • McCutcheon JE, Conrad KL, Carr SB, Ford KA, McGehee DS, Marinelli M. 2012. Dopamine neurons in the ventral tegmental area fire faster in adolescent rats than in adults. J Neurophysiol. 108:1620–1630.
  • McGinty JF, Whitfield TW Jr., Berglind WJ. 2010. Brain-derived neurotrophic factor and cocaine addiction. Brain Res. 1314:183–193.
  • Paxinos G, Watson C. 2005. The rat brain in stereotaxic coordinates. 5th ed. New York: Academic Press.
  • Peters J, Dieppa-Perea LM, Melendez LM, Quirk GJ. 2010. Induction of fear extinction with hippocampal-infralimbic BDNF. Science. 328:1288–1290.
  • Ren Q, Ma M, Yang C, Zhang JC, Yao W, Hashimoto K. 2015. BDNF-TrkB signaling in the nucleus accumbens shell of mice has key role in methamphetamine withdrawal symptoms. Transl Psychiatry. 5:e666.
  • Roberts-Wolfe DJ, Kalivas PW. 2015. Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders. CNS Neurol Disord Drug Targets. 14:745–756.
  • Rodriguez-Kern A, Gegelashvili M, Schousboe A, Zhang J, Sung L, Gegelashvili G. 2003. Beta-amyloid and brain-derived neurotrophic factor, BDNF, up-regulate the expression of glutamate transporter GLT-1/EAAT2 via different signaling pathways utilizing transcription factor NF-kappaB. Neurochem Int. 43:363–370.
  • Sadri-Vakili G, Kumaresan V, Schmidt HD, Famous KR, Chawla P, Vassoler FM, Overland RP, Xia E, Bass CE, Terwilliger EF, et al. 2010. Cocaine-induced chromatin remodeling increases brain-derived neurotrophic factor transcription in the rat medial prefrontal cortex, which alters the reinforcing efficacy of cocaine. J Neurosci. 30:11735–11744.
  • Scofield MD, Heinsbroek JA, Gipson CD, Kupchik YM, Spencer S, Smith AC, Roberts-Wolfe D, Kalivas PW. 2016. The nucleus accumbens: mechanisms of addiction across drug classes reflect the importance of glutamate homeostasis. Pharmacol Rev. 68:816–871.
  • Shapiro LP, Parsons RG, Koleske AJ, Gourley SL. 2017. Differential expression of cytoskeletal regulatory factors in the adolescent prefrontal cortex: Implications for cortical development. J Neurosci Res. 95:1123–1143.
  • Verheij MM, Vendruscolo LF, Caffino L, Giannotti G, Cazorla M, Fumagalli F, Riva MA, Homberg JR, Koob GF, Contet C. 2016. Systemic delivery of a brain-penetrant TrkB antagonist reduces cocaine self-administration and normalizes TrkB signaling in the nucleus accumbens and prefrontal cortex. J Neurosci. 36:8149–8159.
  • Whitfield TW, Jr., Shi X, Sun WL, McGinty JF. 2011. The suppressive effect of an intra-prefrontal cortical infusion of BDNF on cocaine-seeking is Trk receptor and extracellular signal-regulated protein kinase mitogen-activated protein kinase dependent. J Neurosci. 31:834–842.
  • Zweifel LS, Parker JG, Lobb CJ, Rainwater A, Wall VZ, Fadok JP, Darvas M, Kim MJ, Mizumori SJ, Paladini CA, et al. 2009. Disruption of NMDAR-dependent burst firing by dopamine neurons provides selective assessment of phasic dopamine-dependent behavior. Proc Natl Acad Sci USA. 106:7281–7288.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.